- Join thousands of UK patients finding relief with Cannabis Prescriptions UK. Book your free consultation today.
Diazepam was once prescribed so freely that it earned the nickname “mother’s little helper.” Today, it is understood very differently, as a short-term tool with serious risks when used long-term, and one of the hardest drugs to stop taking once the body has adapted to it.
If you’ve been prescribed diazepam for anxiety, muscle spasm, or sleep, and you’re beginning to feel uncertain about continuing, this page is for you. Understanding what diazepam does, what stopping it involves, and what alternatives exist is an important part of making informed decisions about your care.
Diazepam is a benzodiazepine and a Schedule 4 Part 1 controlled drug in the UK. NICE guidance and the British National Formulary are explicit: diazepam should be prescribed for no longer than 2–4 weeks, and only for severe, disabling anxiety or acute muscle spasm.
Typical doses range from 2mg to 10mg, taken two to four times daily for anxiety, or as a single dose of 2–15mg for muscle spasm. For sleep, doses of 5–15mg at night are used. Despite the clear short-term prescribing guidance, a substantial proportion of UK patients remain on benzodiazepines long-term, often because they were never adequately supported to come off them, or because the tapering process was not well managed.
The NHS acknowledges this explicitly: long-term benzodiazepine prescribing is a recognised problem in UK primary care, and active national programmes are attempting to reduce the number of people on long-term prescriptions.
Diazepam withdrawal is among the most medically serious of any drug, more so than opioids in some respects. The body adapts to suppressed GABA-A receptor activity quickly, and when diazepam is reduced, the nervous system rebounds into a hyperexcitable state that can cause:
This is why diazepam should never be stopped abruptly after prolonged use. The Ashton Manual, developed by Professor Heather Ashton at Newcastle University, remains the gold standard resource for benzodiazepine tapering and recommends reductions of no more than 10% of the current dose every 2–4 weeks, with the total withdrawal process sometimes taking a year or more.
Medical cannabis refers to cannabis-based treatments prescribed by specialist clinicians for conditions including anxiety, PTSD, sleep disorders, chronic pain, and muscle spasm, several of which overlap directly with diazepam’s approved indications. It has been legal to prescribe in the UK since 2018.
The cannabinoids THC and CBD interact with the endocannabinoid system, which plays a role in regulating anxiety responses, stress resilience, sleep architecture, and muscle tension. Crucially, the endocannabinoid system and the GABA system that diazepam targets are distinct, meaning medical cannabis does not carry the same physical dependence profile or the same withdrawal risks.
The relationship between medical cannabis and benzodiazepine use has been examined in several studies, with mixed but broadly encouraging results in observational settings.
A study published in Cannabis and Cannabinoid Research found that patients prescribed medical cannabis showed a 45% reduction in benzodiazepine use compared to controls. A separate analysis tracking over 9,000 medical cannabis patients in Canada over nearly a decade found reductions in daily diazepam-equivalent use, though the effect was more pronounced in some subgroups than others.
A 2024 systematic review and meta-analysis in Psychiatry Research found that CBD specifically showed significant reductions in anxiety symptoms across multiple studies, with a particularly strong signal in generalised anxiety disorder and PTSD.
It is worth noting that the evidence base is not yet at the standard of large-scale randomised controlled trials. Medical cannabis is not a guaranteed replacement for diazepam, and for some patients, particularly those on very long-term, high-dose benzodiazepines, it forms one part of a broader tapering support strategy rather than a direct switch.
| Diazepam | Medical Cannabis | |
| Mechanism | GABA-A receptor potentiation | Endocannabinoid system modulation |
| Recommended duration | 2–4 weeks | Ongoing under specialist review |
| Dependence risk | Very high — develops within weeks | Lower, but possible |
| Withdrawal severity | Severe — seizure risk, can be fatal | Mild — irritability, sleep disruption |
| Targets | Anxiety, muscle spasm, sleep | Anxiety, sleep, pain, mood |
| UK legal status | Schedule 4 Part 1 controlled drug | Legal with specialist prescription since 2018 |
People who come to us after long-term diazepam use tend to describe a particular kind of frustration. The drug worked, at first. But over time, the anxiety it was prescribed to treat crept back, and the dose that once brought relief began to feel like maintenance rather than treatment. Attempts to reduce often brought the original symptoms back with new intensity, making it hard to know whether it was the anxiety returning or the medication causing withdrawal.
Medical cannabis is not a simple swap for diazepam, and we would never suggest stopping diazepam without proper medical guidance. What it can offer is a different conversation, one that explores whether other tools might support your anxiety and sleep while a carefully managed tapering process takes place.
If you’re currently using diazepam or have previously been prescribed it and are interested in learning whether medical cannabis could be suitable for your condition, an eligibility assessment can help provide clarity.
Take our free eligibility check today to see whether you may qualify for a medical cannabis consultation.
Medical Disclaimer
This content is intended for general informational purposes only and does not constitute medical advice. Medical cannabis should be used under the supervision of a qualified healthcare professional in accordance with UK regulations.
